» Articles » PMID: 37842920

, an Oral Pathobiont Associated with Colorectal Cancer, Epigenetically Reprograms Human Colonocytes

Abstract

Recently, an intestinal dysbiotic microbiota with enrichment in oral cavity bacteria has been described in colorectal cancer (CRC) patients. Here, we characterize and investigate one of these oral pathobionts, the Gram-positive anaerobic coccus . We identified two phylotypes (A and B) exhibiting different phenotypes and adhesion capabilities. We observed a strong association of phylotype A with CRC, with its higher abundance in feces and in tumoral tissue compared with the normal homologous colonic mucosa, which was associated with a distinct methylation status of patients. By developing an hypoxic co-culture system of human primary colonic cells with anaerobic bacteria, we show that phylotype A alters the DNA methylation profile promoters of key tumor-suppressor genes, oncogenes, and genes involved in epithelial-mesenchymal transition. In colonic mucosa of CRC patients carrying phylotype A, we found similar DNA methylation alterations, together with significant enrichment of differentially expressed genes in pathways involved in inflammation, cell adhesion, and regulation of actin cytoskeleton, providing evidence of possible role in the carcinogenic process.

Citing Articles

Novel therapeutic strategies and recent advances in gut microbiota synergy with nanotechnology for colorectal cancer treatment.

Han Q, Li J, Li Z, Aishajiang R, Yu D Mater Today Bio. 2025; 31:101601.

PMID: 40066079 PMC: 11891152. DOI: 10.1016/j.mtbio.2025.101601.


Is the oral pathogen, Porphyromona gingivalis, associated to colorectal cancer?: a systematic review.

Navarro-Sanchez A, Nieto-Vitoria M, Lopez-Lopez J, Martinez-Crespo J, Navarro-Mateu F BMC Cancer. 2025; 25(1):395.

PMID: 40038641 PMC: 11881450. DOI: 10.1186/s12885-025-13770-4.


Differences in diversity and composition of mucosa-associated colonic microbiota in colorectal cancer and non-colorectal cancer in Indonesia.

Darnindro N, Abdullah M, Sukartini N, Rumende C, Pitarini A, Nursyirwan S World J Gastroenterol. 2025; 31(7):100051.

PMID: 39991683 PMC: 11755252. DOI: 10.3748/wjg.v31.i7.100051.


promotes tumor progression via the Integrin α2/β1-PI3K-AKT-mTOR-C-myc signaling pathway in colorectal cancer.

Chen Y, Qin Y, Fan T, Qiu C, Zhang Y, Dai M Int J Biol Sci. 2025; 21(4):1497-1512.

PMID: 39990665 PMC: 11844286. DOI: 10.7150/ijbs.102742.


Proton Pump Inhibitors and Oral-Gut Microbiota: From Mechanism to Clinical Significance.

Zhang X, Li Q, Xia S, He Y, Liu Y, Yang J Biomedicines. 2024; 12(10).

PMID: 39457584 PMC: 11504961. DOI: 10.3390/biomedicines12102271.


References
1.
Murdoch D, Mitchelmore I, TABAQCHALI S . Peptostreptococcus micros in polymicrobial abscesses. Lancet. 1988; 1(8585):594. DOI: 10.1016/s0140-6736(88)91393-1. View

2.
Drewes J, White J, Dejea C, Fathi P, Iyadorai T, Vadivelu J . High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia. NPJ Biofilms Microbiomes. 2017; 3:34. PMC: 5707393. DOI: 10.1038/s41522-017-0040-3. View

3.
Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View

4.
Wettenhall J, Smyth G . limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics. 2004; 20(18):3705-6. DOI: 10.1093/bioinformatics/bth449. View

5.
Bagci C, Beier S, Gorska A, Huson D . Introduction to the Analysis of Environmental Sequences: Metagenomics with MEGAN. Methods Mol Biol. 2019; 1910:591-604. DOI: 10.1007/978-1-4939-9074-0_19. View